Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03234530 · ClinicalTrials.gov registry record
World Trade Center Kidney-Link
A clinical trial of Obstructive Sleep Apnea and Chronic Kidney Diseases, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 555
- Enrollment target
- 1
- Study location
NCT03234530 is a study of Obstructive Sleep Apnea and Chronic Kidney Diseases that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 555 participants, above the 218-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (155% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03234530, a study of Obstructive Sleep Apnea and Chronic Kidney Diseases, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 555 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on the prevalence and identification of kidney disease among participants of the WTC Health Program and the study team are planning to assess kidney disease in a multi-factorial manner. The first aim of this study is to correlate kidney dysfunction with 9/11 exposure, and the study team predicts that exposure to 9/11 is an independent risk factor in kidney disease among the WTC Health Program participants. Secondly, the study team proposes that a well-established WTC-related condition, obstructive sleep apnea (OSA), is independently associated with kidney disease. In addition, the study team believe there is a temporal causative relationship between evidence of kidney disease and the severity of OSA. Finally, the last aim is to further identify and explore potential mechanisms and phenotypes of kidney disease in participants of the WTC Health Programs. Regardless of whether the analyses support or reject these hypotheses, the findings will be of equally great public health importance. Successful completion of the proposed research would address a critical knowledge gap regarding the risk of kidney damage among this group of patients, and would inform future mechanistic studies with the potential to impact prevention.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 555 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2021-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03234530
The ClinicalTrials.gov registry entry for NCT03234530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 555 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (155% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT03234530 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03234530 about?
NCT03234530 is a clinical study titled "World Trade Center Kidney-Link". This study focuses on the prevalence and identification of kidney disease among participants of the WTC Health Program and the study team are planning to assess kidney disease in a multi-factorial manner. The first aim of this study is to correlate kidney dysfunction with 9/11 exposure, and the stud...
What is the current status of trial NCT03234530?
This trial is currently completed. The enrollment target is 555 participants. The study started on 2017-11-01. Estimated completion is 2021-06-01.
What conditions does trial NCT03234530 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Chronic Kidney Diseases.
Who is sponsoring clinical trial NCT03234530?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03234530 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.